Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Miller

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
BMC Gastroenterology|November 20, 2014
Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled studyPhilip B Miner, Debra G Silberg, Magnus Ruth, et al.
Abdominal Radiology (New York)|March 28, 2019
Imaging features of immune-mediated genitourinary diseaseJonathon Weber, Nancy Hammond, Vahid Yaghmai, et al.
Gastrointestinal Endoscopy|June 7, 2008
Endoscopic and EUS features of groove pancreatitis masquerading as a pancreatic neoplasmAlberto Herreros de Tejada, Jennifer Chennat, Frank Miller, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 30, 2012
Effect of food on the bioavailability of lesogaberan given as an oral solution or as modified-release capsules in healthy male volunteersBo Fransson, Debra G Silberg, Mohammad Niazi, et al.
Journal of Biopharmaceutical Statistics|September 18, 2015
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic reviewThomas Ondra, Alex Dmitrienko, Tim Friede, et al.
International Clinical Psychopharmacology|February 28, 2008
Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophreniaHans-Jürgen Möller, Sunny Johnson, Temenuzhka Mateva, et al.
Biometrical Journal. Biometrische Zeitschrift|May 18, 2016
Determination of the optimal sample size for a clinical trial accounting for the population sizeNigel Stallard, Frank Miller, Simon Day, et al.
Psychiatry (Edgmont (Pa. : Township))|April 30, 2010
Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patientsJoseph Peuskens, Jitendra Trivedi, Sergiy Malyarov, et al.
BMC Medical Research Methodology|February 10, 2018
Value of information methods to design a clinical trial in a small population to optimise a health economic utility functionMichael Pearce, Siew Wan Hee, Jason Madan, et al.
Statistical Methods in Medical Research|June 7, 2015
Decision-theoretic designs for small trials and pilot studies: A reviewSiew Wan Hee, Thomas Hamborg, Simon Day, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
BMC Gastroenterology|November 20, 2014
Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled studyPhilip B Miner, Debra G Silberg, Magnus Ruth, et al.
Abdominal Radiology (New York)|March 28, 2019
Imaging features of immune-mediated genitourinary diseaseJonathon Weber, Nancy Hammond, Vahid Yaghmai, et al.
Gastrointestinal Endoscopy|June 7, 2008
Endoscopic and EUS features of groove pancreatitis masquerading as a pancreatic neoplasmAlberto Herreros de Tejada, Jennifer Chennat, Frank Miller, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 30, 2012
Effect of food on the bioavailability of lesogaberan given as an oral solution or as modified-release capsules in healthy male volunteersBo Fransson, Debra G Silberg, Mohammad Niazi, et al.
Journal of Biopharmaceutical Statistics|September 18, 2015
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic reviewThomas Ondra, Alex Dmitrienko, Tim Friede, et al.
International Clinical Psychopharmacology|February 28, 2008
Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophreniaHans-Jürgen Möller, Sunny Johnson, Temenuzhka Mateva, et al.
Biometrical Journal. Biometrische Zeitschrift|May 18, 2016
Determination of the optimal sample size for a clinical trial accounting for the population sizeNigel Stallard, Frank Miller, Simon Day, et al.
Psychiatry (Edgmont (Pa. : Township))|April 30, 2010
Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patientsJoseph Peuskens, Jitendra Trivedi, Sergiy Malyarov, et al.
BMC Medical Research Methodology|February 10, 2018
Value of information methods to design a clinical trial in a small population to optimise a health economic utility functionMichael Pearce, Siew Wan Hee, Jason Madan, et al.
Statistical Methods in Medical Research|June 7, 2015
Decision-theoretic designs for small trials and pilot studies: A reviewSiew Wan Hee, Thomas Hamborg, Simon Day, et al.
Pageof 6